SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brander who wrote (4771)7/11/1998 11:10:00 PM
From: Bill Wexler  Read Replies (1) of 7041
 
<<Concerning the patent, I believe that they do have a legitimate patent for their product. It was not purchased with cheap stock.>>

Incorrect on both counts. The first patent covers various delivery methods for phentolamine (e.g. transmucosal). The patent actually downplays oral administration. For months, Zonagen shills tried to spin this patent by claiming that Vasomax would be placed under the tounge. The patent was indeed paid for with stock (I'm not sure if additional cash was involved.). The second patent was owned by a former Zonagen emplyee and only covers a certain mixture of inert ingredients and a disintegrant - the so-called "fast acting" formulation. Problem is that oral phentolamine is hardly "fast acting". Shills tried to spin this one as well.

<<Also, the clinical trial suggest that Zonagen is helpful in treating ED>>

Bullsh*t.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext